Financial Performance - The company reported revenue of approximately HKD 495,377,000 for the twelve months ending December 31, 2021, a decrease of 12.7% compared to HKD 567,553,000 for the same period in 2020[7]. - Gross profit for the same period was approximately HKD 37,577,000, with a gross margin of 7.6%, down from HKD 48,930,000 and 8.6% in the previous year, respectively[7]. - The company recorded a loss attributable to owners of approximately HKD 17,027,000, compared to a loss of HKD 8,149,000 in the prior year, primarily due to decreased revenue and increased interest expenses on convertible bonds[8]. - Revenue for the year ended December 31, 2021, was HKD 495,377,000, a decrease of 12.7% from HKD 567,553,000 in 2020[37]. - Gross profit for 2021 was HKD 37,577,000, down 23.2% from HKD 48,930,000 in the previous year[37]. - The company reported a loss of HKD 12,647,000 for the year, compared to a profit of HKD 995,000 in 2020, marking a significant decline[39]. - Basic and diluted loss per share for 2021 was HKD 1.02, compared to HKD 0.49 in 2020[37]. - Total comprehensive loss for the year was HKD 10,809,000, compared to a comprehensive income of HKD 4,202,000 in 2020[39]. - The company recorded a loss attributable to owners of approximately HKD 17,027,000 for the year ended December 31, 2021, highlighting ongoing financial challenges[51]. - The total comprehensive loss for the year ended December 31, 2021, was HKD 12,647 compared to a profit of HKD 995 in 2020[61][63]. Assets and Liabilities - The company's current liabilities net worth was approximately HKD 62,513,000 as of December 31, 2021, compared to HKD 59,742,000 a year earlier[9]. - Non-current assets decreased to HKD 92,423,000 in 2021 from HKD 98,074,000 in 2020[41]. - Current assets increased to HKD 93,917,000 in 2021 from HKD 90,247,000 in 2020, driven by an increase in trade receivables[41]. - Current liabilities and net debt as of December 31, 2021, were approximately HKD 62,513,000 and HKD 23,778,000, respectively, indicating significant financial obligations[51]. - Total liabilities as of December 31, 2021, were HKD 210,118, an increase from HKD 201,290 in 2020[65][68]. - The company’s equity attributable to owners decreased to HKD (53,578,000) in 2021 from HKD (37,488,000) in 2020[42]. - Trade receivables increased to HKD 23,761,000 as of December 31, 2021, compared to HKD 16,796,000 in 2020, reflecting a growth of 41.4%[94]. - Total borrowings increased from HKD 73,762,000 in 2020 to HKD 85,016,000 in 2021, with shareholder loans rising from HKD 6,732,000 to HKD 16,420,000[100]. Cash Flow - The company reported a net cash outflow from operating activities of HKD (9,400,000) for the year ended December 31, 2021, compared to HKD (413,000) in 2020, indicating a significant decline in operational cash flow[46]. - The company incurred a net cash outflow from investing activities of HKD (284,000) in 2021, a decrease from HKD (12,523,000) in the previous year, reflecting reduced investment expenditures[46]. - Financing activities generated a net cash inflow of HKD 5,596,000 in 2021, down from HKD 11,534,000 in 2020, primarily due to changes in borrowing and repayment activities[46]. - The company’s cash and cash equivalents decreased to HKD 4,644,000 at year-end 2021 from HKD 5,446,000 at the beginning of the year, reflecting liquidity pressures[46]. Strategic Plans - The company plans to continue strategic acquisitions to capture new opportunities in the Chinese market and strengthen its revenue and profit base[13]. - The company is actively seeking growth projects for acquisition or investment, indicating a proactive approach to market expansion[54]. - The company plans to continue focusing on its core business segments and may explore opportunities for market expansion in the future[74]. - The company plans to continue exploring market expansion opportunities and new product development strategies in the upcoming fiscal year[99]. Corporate Governance - The board has resolved not to declare a second interim dividend for the twelve months ending December 31, 2021[14]. - The group did not declare any interim dividend for the twelve months ended December 31, 2021, consistent with the previous year[85]. - The company has complied with the corporate governance code, except for the separation of the roles of Chairman and CEO, which are held by Lin Qingqu[31]. Shareholder Information - As of December 31, 2021, the major shareholders include Lin Qingqu, who holds 28,004,000 shares (1.67%) and has control over 811,502,432 shares (48.28%) through related companies[20]. - The company has a total of 811,502,432 shares held by China Success Limited, which is wholly owned by Wei Jun Investment Fund[21]. - The company has a total of 141,270,400 shares held by Fair Concourse Limited, owned by Mai Xiuqun[29]. - The total number of issued ordinary shares decreased from 16,590,685,376 in 2020 to 1,680,764,537 in 2021 due to a share consolidation[108]. - The total number of convertible preferred shares decreased from 816,000,000 to 81,600,000 after the share consolidation, with issued preferred shares reduced from 216,960,000 to 21,696,000[114]. Risk Management - The company faces various financial risks, including market risk, credit risk, and liquidity risk, which are detailed in the annual financial statements[123]. - The company has not made significant changes to its risk management policies since December 31, 2020, maintaining its approach to financial risk management[124].
玮俊生物科技(00660) - 2022 - 中期财报